| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.001 | 1 |